187 related articles for article (PubMed ID: 17339498)
1. FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.
Wu J; Ji C; Xie F; Langefeld CD; Qian K; Gibson AW; Edberg JC; Kimberly RP
J Immunol; 2007 Mar; 178(6):3973-82. PubMed ID: 17339498
[TBL] [Abstract][Full Text] [Related]
2. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.
Bakema JE; de Haij S; den Hartog-Jager CF; Bakker J; Vidarsson G; van Egmond M; van de Winkel JG; Leusen JH
J Immunol; 2006 Mar; 176(6):3603-10. PubMed ID: 16517729
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
Hellwig SM; van Spriel AB; Schellekens JF; Mooi FR; van de Winkel JG
Infect Immun; 2001 Aug; 69(8):4846-50. PubMed ID: 11447159
[TBL] [Abstract][Full Text] [Related]
4. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
[TBL] [Abstract][Full Text] [Related]
5. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
van Egmond M; van Garderen E; van Spriel AB; Damen CA; van Amersfoort ES; van Zandbergen G; van Hattum J; Kuiper J; van de Winkel JG
Nat Med; 2000 Jun; 6(6):680-5. PubMed ID: 10835685
[TBL] [Abstract][Full Text] [Related]
6. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein.
Lu J; Marjon KD; Marnell LL; Wang R; Mold C; Du Clos TW; Sun P
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4974-9. PubMed ID: 21383176
[TBL] [Abstract][Full Text] [Related]
7. A novel polymorphism of FcalphaRI (CD89) associated with aggressive periodontitis.
Kaneko S; Kobayashi T; Yamamoto K; Jansen MD; van de Winkel JG; Yoshie H
Tissue Antigens; 2004 Jun; 63(6):572-7. PubMed ID: 15140034
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells.
Pasquier B; Lepelletier Y; Baude C; Hermine O; Monteiro RC
J Leukoc Biol; 2004 Dec; 76(6):1134-41. PubMed ID: 15371488
[TBL] [Abstract][Full Text] [Related]
9. Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18).
van Egmond M; van Vuuren AJ; Morton HC; van Spriel AB; Shen L; Hofhuis FM; Saito T; Mayadas TN; Verbeek JS; van de Winkel JG
Blood; 1999 Jun; 93(12):4387-94. PubMed ID: 10361137
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
11. IgA Fc receptors.
Monteiro RC; Van De Winkel JG
Annu Rev Immunol; 2003; 21():177-204. PubMed ID: 12524384
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89).
van Egmond M; van Spriel AB; Vermeulen H; Huls G; van Garderen E; van de Winkel JG
Cancer Res; 2001 May; 61(10):4055-60. PubMed ID: 11358825
[TBL] [Abstract][Full Text] [Related]
13. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
Heineke MH; van der Steen LPE; Korthouwer RM; Hage JJ; Langedijk JPM; Benschop JJ; Bakema JE; Slootstra JW; van Egmond M
Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
[TBL] [Abstract][Full Text] [Related]
14. Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89.
van Zandbergen G; Westerhuis R; Mohamad NK; van De Winkel JG; Daha MR; van Kooten C
J Immunol; 1999 Dec; 163(11):5806-12. PubMed ID: 10570263
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of IgA receptor FcalphaRI on human platelets.
Qian K; Xie F; Gibson AW; Edberg JC; Kimberly RP; Wu J
J Leukoc Biol; 2008 Dec; 84(6):1492-500. PubMed ID: 18784345
[TBL] [Abstract][Full Text] [Related]
16. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.
Bakema JE; van Egmond M
Mucosal Immunol; 2011 Nov; 4(6):612-24. PubMed ID: 21937986
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
[TBL] [Abstract][Full Text] [Related]
18. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
Herr AB; Ballister ER; Bjorkman PJ
Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
van der Pol W; Vidarsson G; Vilé HA; van de Winkel JG; Rodriguez ME
J Infect Dis; 2000 Oct; 182(4):1139-45. PubMed ID: 10979910
[TBL] [Abstract][Full Text] [Related]
20. Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.
Liu C; Kanamaru Y; Watanabe T; Tada N; Horikoshi S; Suzuki Y; Liu Z; Tomino Y
Clin Exp Immunol; 2015 Sep; 181(3):407-16. PubMed ID: 25907714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
